The impact of hepatitis E in the liver transplant setting

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Pathogenesis and Treatment of Hepatitis E Virus Infection
Volume 68, Issue 5, Pages (May 2018)
Volume 61, Issue 6, Pages (December 2014)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Volume 51, Issue 6, Pages (December 2009)
Reactive oxygen species in the normal and acutely injured liver
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
Pathogenesis and Treatment of Hepatitis E Virus Infection
Immigration and viral hepatitis
Virological tools to diagnose and monitor hepatitis C virus infection
Living donor liver transplantation: is the hype over?
Mesenchymal stromal cell therapy for liver diseases
Volume 69, Issue 2, Pages (August 2018)
Volume 44, Pages S19-S24 (January 2006)
Hepatitis B infection in heart transplant recipients
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
The place of downstaging for hepatocellular carcinoma
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
European Association for the Study of the Liver  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Volume 70, Issue 1, Pages (January 2019)
Acute-on chronic liver failure
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Michael Charlton  Clinical Gastroenterology and Hepatology 
Genomic risk of hepatitis C-related hepatocellular carcinoma
Darius Moradpour, Arash Grakoui, Michael P. Manns 
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
EASL Clinical Practice Guidelines: Wilson’s disease
Volume 61, Issue 1, Pages S45-S57 (November 2014)
EASL Clinical Practice Guidelines on hepatitis E virus infection
Sven Pischke, Patrick Behrendt, Michael P Manns, Heiner Wedemeyer 
Volume 50, Issue 4, Pages (April 2009)
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
miR-122 – A key factor and therapeutic target in liver disease
Volume 70, Issue 1, Pages (January 2019)
Volume 50, Issue 3, Pages (March 2009)
Immigration and viral hepatitis
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
Pathogenesis and Treatment of Hepatitis E Virus Infection
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
Volume 51, Issue 2, Pages (August 2009)
Epigenetic modifications as new targets for liver disease therapies
Chronic hepatitis B in children and adolescents
Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice  Paolo Angeli, Pere Gines 
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Reversion of disease manifestations after HCV eradication
Presentation transcript:

The impact of hepatitis E in the liver transplant setting Patrick Behrendt, Eike Steinmann, Michael P. Manns, Heiner Wedemeyer  Journal of Hepatology  Volume 61, Issue 6, Pages 1418-1429 (December 2014) DOI: 10.1016/j.jhep.2014.08.047 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Transmission and disease-progression in transplanted individuals. The possible mode of HEV-transmissions is illustrated. Additionally, known factors which influence the clinical course are depicted. Treatment options are highlighted in blue. Journal of Hepatology 2014 61, 1418-1429DOI: (10.1016/j.jhep.2014.08.047) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Clinical signs and serological markers during HEV infection over time. (A) acute and (B) chronic HEV infection. Journal of Hepatology 2014 61, 1418-1429DOI: (10.1016/j.jhep.2014.08.047) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2014 61, 1418-1429DOI: (10. 1016/j. jhep. 2014 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions